Acadian Asset Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$693K Buy
2,108,336
+20,290
+1% +$6.67K ﹤0.01% 1067
2025
Q1
$650K Buy
2,088,046
+237,445
+13% +$73.9K ﹤0.01% 1023
2024
Q4
$1.73M Buy
1,850,601
+3,267
+0.2% +$3.05K 0.01% 801
2024
Q3
$2.18M Buy
1,847,334
+182,782
+11% +$215K 0.01% 723
2024
Q2
$1.28M Buy
1,664,552
+8,681
+0.5% +$6.67K ﹤0.01% 914
2024
Q1
$5.05M Hold
1,655,871
0.02% 465
2023
Q4
$5.33M Sell
1,655,871
-45,357
-3% -$146K 0.02% 430
2023
Q3
$6.53M Sell
1,701,228
-79,502
-4% -$305K 0.03% 362
2023
Q2
$5.84M Sell
1,780,730
-143
-0% -$469 0.02% 413
2023
Q1
$4.59M Sell
1,780,873
-33,689
-2% -$86.9K 0.02% 480
2022
Q4
$3.37M Sell
1,814,562
-14,790
-0.8% -$27.5K 0.02% 547
2022
Q3
$3.36M Sell
1,829,352
-122,111
-6% -$224K 0.02% 506
2022
Q2
$4.2M Sell
1,951,463
-187,827
-9% -$404K 0.02% 456
2022
Q1
$6.72M Buy
2,139,290
+99,206
+5% +$311K 0.03% 394
2021
Q4
$6.54M Buy
2,040,084
+136,922
+7% +$439K 0.02% 403
2021
Q3
$6.39M Buy
1,903,162
+64,916
+4% +$218K 0.02% 401
2021
Q2
$7.19M Buy
1,838,246
+875,770
+91% +$3.42M 0.03% 381
2021
Q1
$3.87M Buy
962,476
+609,818
+173% +$2.45M 0.02% 535
2020
Q4
$815K Buy
+352,658
New +$815K ﹤0.01% 1051
2020
Q3
Sell
-4,164
Closed -$31K 2310
2020
Q2
$31K Sell
4,164
-91,574
-96% -$682K ﹤0.01% 2031
2020
Q1
$285K Sell
95,738
-132,622
-58% -$395K ﹤0.01% 1111
2019
Q4
$947K Sell
228,360
-4,378
-2% -$18.2K ﹤0.01% 890
2019
Q3
$755K Buy
232,738
+21,248
+10% +$68.9K ﹤0.01% 975
2019
Q2
$392K Buy
211,490
+57,592
+37% +$107K ﹤0.01% 1072
2019
Q1
$272K Buy
153,898
+125,690
+446% +$222K ﹤0.01% 1276
2018
Q4
$68K Hold
28,208
﹤0.01% 1361
2018
Q3
$160K Buy
28,208
+8,479
+43% +$48.1K ﹤0.01% 1111
2018
Q2
$154K Buy
19,729
+12,294
+165% +$96K ﹤0.01% 1144
2018
Q1
$52K Buy
+7,435
New +$52K ﹤0.01% 1347